Shilpa Medicare
SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com

Stock Price vs Company Growth
1d
1.8%
1w
4.2%
1m
3.8%
3m
17.9%
6m
65.7%
1y
133.6%
5y
21.9%
10y
12.0%
all
18.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 833 1.8%
662
960
Company Overview

Sales
1,184 Cr
Growth: 6.6%
Profit after Tax
38.6 Cr
Growth: 50.0%
Mid Cap
8,149 Cr
P/E: 166.8x
Industry P/E: 41.5x
Fundamentals

Sales (Cr) ₹ 1,184
Growth 6.6%
EBITDA 22.8%
P/S 6.9x
Dividend 0.0%
P/E 166.8x
Book Value ₹ 187
PEG Ratio 24.9x
ROE 2.1%
P/B 4.4x
Shareholding Pattern

Institutions
Ta Fii Investors Fund
3.71 %
Tano Mauritius India Fvci Ii
2.43 %
Pivotal Enterprises Private Limited
2.35 %
Pivotal Business Managers Llp
1.75 %
Duro One Investments Limited
1.42 %
Promoters
Vishnukant Chaturbhuj Bhutada
7.81 %
Dharmavati Bhutada
7.61 %
Ravi Kumar Innani
4.91 %
Suraj Kumar Innani
4.88 %
Ramakant Innani
4.29 %
Others
Increase    Decrease    No change
Company Profile Detailed

Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Investors (146)
Followers (7)